Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by G1945Von Sep 15, 2022 8:13am
111 Views
Post# 34963827

RE:Life Changing Technology

RE:Life Changing Technology
Jennifer2020 wrote:
Practically all top heart institutes have a VMS unit now with Duke Univ. , Mazankowski Heart Institute, Stollery Children's Hosp. & Toronto's Children's Hosp mentioned in the last year. 15 important studies used VMS or are underway at places such as Harvard, King's College London and Cedar Sinai. Countries using VMS also include such places as China, Belgium and Switzerland. It's taken 10 years to develop VMS's patented KBR AI and Ventripoint is now partnered with a multi-billion dollar giant GE Health Care in the best of all circumstances in a non-exclusive agreement. The week of GEHC's Nasdaq debut has been announced and true auto Vivid 4D Echopac plus has been demonstrated and is going to be fully promoted as the spinco date approaches. The buyout price for VPT shareholders on CEO.CA range from $1 to $5 so we are looking at a minimum triple bagger from here.


https://www.nasdaq.com/articles/ge-announces-brand-names-for-future-public-companies-ge-aerospace-to-own-ge-trademark

"Following the completion of the planned spin-off, shares of GE HealthCare will be listed on the Nasdaq Global Select Market under the ticker symbol, GEHC."



Don't get left behind...DYODD...GLTA
G1945V

<< Previous
Bullboard Posts
Next >>